Intellectual Property Cases
Cases 81 - 90 of 485
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
as 1:2019cv02202
Defendant: Teva Pharmaceuticals USA, Inc.
Plaintiff: Vanda Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 1
Vanda Pharmaceuticals Inc. v. Teva Pharmaceuticals USA, Inc.
as 1:2020cv00093
Defendant: Teva Pharmaceuticals USA, Inc.
Plaintiff: Vanda Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 1
ELI LILLY AND COMPANY v. ACTAVIS LLC et al
as 1:2017cv00982
Defendant: ACTAVIS LLC, TEVA PHARMACEUTICALS USA, INC. and TEVA PHARMACEUTICAL INDUSTRIES LTD.
Plaintiff: ELI LILLY AND COMPANY
Cause Of Action: 35 U.S.C. § 145
Merck Sharp & Dohme Corp. et al v. Actavis Laboratories FL, Inc. et al
as 0:2020cv60110
Defendant: Teva Pharmaceuticals USA, Inc., Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.
Plaintiff: MSD Investment Holdings (Ireland), Optimer Pharmaceuticals LLC, Merck Sharp & Dohme Corp. and others
Cause Of Action: 15 U.S.C. § 1126
MERK SHARP & DOHME CORP. et al v. ACTAVIS LABORATORIES FL, INC. et al
as 2:2020cv00533
Defendant: TEVA PHARMACEUTICALS USA, INC., ACTAVIS LABORATORIES FL, INC. and ACTAVIS PHARMA, INC.
Plaintiff: MSD INVESTMENT HOLDINGS (IRELAND), OPTIMER PHARMACEUTICALS LLC, MSD INTERNATIONAL GMBH and others
Cause Of Action: 15 U.S.C. § 1126
IBSA Institut Biochimique SA et al v. Teva Pharmaceutical USA, Inc.
as 1:2019cv02115
Plaintiff: Altergon SA, IBSA Pharma Inc. and IBSA Institut Biochimique SA
Defendant: Teva Pharmaceutical USA, Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Alkem Laboratories Ltd. et al We have downloadable decisions or orders for this case
as 1:2019cv01979
Defendant: Teva Pharmaceuticals USA, Inc., Aurobindo Pharma USA Inc., Lupin Inc. and others
Plaintiff: Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
Otsuka Pharmaceutical Co., Ltd. et al v. Teva Pharmaceuticals USA, Inc. et al
as 1:2019cv01955
Defendant: Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd.
Plaintiff: Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S
Cause Of Action: 35 U.S.C. § 271
Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc.
as 17-2078
Amicus Curiae: BIOTECHNOLOGY INNOVATION ORGANIZATION and PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Defendant / Appellee: ROXANE LABORATORIES, INC. and TEVA PHARMACEUTICALS USA, INC.
Defendant / Cross Appellant: MYLAN PHARMACEUTICALS INC.
Plaintiff / Appellee: ALKERMES PHARMA IRELAND LIMITED
Plaintiff / Appellant: ACORDA THERAPEUTICS, INC.
CyDex Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc. et al
as 1:2017cv01832
Defendant: Teva Pharmaceuticals USA, Inc., Actavis LLC and Teva Pharmaceutical Industries Ltd.
Plaintiff: CyDex Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?